Nouf Alluqmani

University of Ottawa — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index186citations13works12.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(9), CAR-T cell therapy research(6), Immunotherapy and Immune Responses(4), SARS-CoV-2 and COVID-19 Research(3), interferon and immune responses(3)

Publications13 total

Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy
Nature Communications·2024· 12 citedOpen Access
838 Oncolytic virus induced tumour-infiltrating lymphocytes (TILs) for the treatment of colorectal cancer
Regular and Young Investigator Award Abstracts·2023Open Access
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
Molecular Therapy — Methods & Clinical Development·2023· 11 citedOpen Access
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus
Frontiers in Immunology·2023· 10 citedOpen Access
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
Frontiers in Immunology·2023· 12 citedOpen Access
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines
Frontiers in Immunology·2022· 10 citedOpen Access
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer
Frontiers in Immunology·2022· 29 citedOpen Access
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
Molecular Therapy·2022· 6 citedOpen Access
Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy
Molecular Therapy — Oncolytics·2022· 8 citedOpen Access
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Nature Communications·2022· 46 citedOpen Access
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
Molecular Therapy·2021· 26 citedOpen Access
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy
Communications Biology·2020· 16 citedOpen Access
Impact of viral sensitizer-enhanced oncolytic virus immunotherapy on the anti-tumor immune response
The Journal of Immunology·2020

Frequent Co-authors

Jean‐Simon Diallo(12), Zaid Taha(11), Mathieu J. F. Crupi(9), John C. Bell(9), Carolina S. Ilkow(8), Rozanne Arulanandam(8), Julia Petryk(7), Stephen Boulton(7), Taha Azad(6), Bradley Austin(5), Ragunath Singaravelu(5), Joanna Poutou(4), Adrian Pelin(4), S. Khan(4), Xiaohong He(4), Anna Jirovec(4), Ricardo Marius(4), Andrew Chen(4), Taylor R. Jamieson(3), Christiano Tanese de Souza(3)